A desalination system (100) having an intake unit (110) providing seawater to a pre-treatment unit (120) connected to a reverse osmosis (RO) desalination unit (130) and a post treatment unit (150). The desalination system (100) is configured to operate without any external addition of chemicals to simplify logistics and regulation concerns. The units of the system are configured to prevent biofouling, scaling and corrosion by mechanical and biological means including high flow speeds, biological flocculation of colloids, and making the water entering the RO units inhospitable to bacteria and other organisms that cause biofouling, hence preventing their settlement and removing them with the brine. Recovery rate is lowered and energy is recovered to increase the energetic efficiency and minerals that are added to the product water are taken from the brine.

A drinking water vending dispenser for dispensing purified water comprising a coarse mechanical filter, an RO purification unit, an ozone purification unit, a UV purification unit, an active carbon filter, a chemical base purification unit and a fine mechanical filter.

A technology that provides various modular biomimetic microfluidic modules emulating varieties of microvasculature in body. These microfluidic-base capillaries and lymphatic Technology modules are constructed as multilayered-microfluidic microchannels of various shapes, and aspect ratios using diverse biocompatible microfluidic polymers. Then, various semipermeable membranes are sandwiched in between these multilayered microfluidic microchannels. These membranes have different chemical, physical characteristics and MWCO values. Consequently, this design will produce much smaller dimension channels similar to human vasculature to achieve biomimetic properties like of human organs and tissues. By interchanging microfluidic-layers or the membranes various diverse modules are designed that act as building blocks for constructing various medical devices, various forms of dialysis devices including albumin and lipid dialysis, water purification, bioreactors, bio-artificial organ support systems. Connecting various modules in diverse combinations, permutations, in parallel and/or in series to ultimately design many unrelated medical devices such as dialysis, bioreactors and organ support devices.

A membrane separation pretreatment apparatus including a membrane separation unit and a first underwater plasma discharge unit disposed in front of the membrane separation unit is provided. The membrane separation pretreatment apparatus includes a membrane separation unit configured to remove particulate matter contained in raw water, and a first underwater plasma discharge unit disposed in front of the membrane separation unit and configured to cause a portion of the raw water to be introduced into the membrane separation unit to perform underwater plasma discharging.

A water filter cartridge includes a sediment filter, a carbon filter, and a core having a tubular body with openings that allow water to flow through the core. The core defines an open central area, and the core supports the sediment filter and the carbon filter. A nanofiltration unit is arranged within the open central area of the core. The nanofiltration unit includes a tubular filter element defining a central volume, and a plurality of filaments arranged within the central volume.

Processes for the production of bags containing saline solution. The processes include sealing bags with crystalline components and then sterilizing the sealed bags with crystalline components. The bags may be sterilized in an autoclave and then transported to a consumption site which produces water-for-injection (WFI) suitable for use in an IV bag. The WFI is added to the sterilized bags, dissolving the solid salt (USP-grade sodium chloride), to produce a bag with a 0.9 w/v % normal saline solution.

Processes for the production of bags containing saline solution. The processes include sealing bags with crystalline components and then sterilizing the sealed bags with crystalline components. The bags may be sterilized in an autoclave and then transported to a consumption site which produces water-for-injection (WFI) suitable for use in an IV bag. The WFI is added to the sterilized bags, dissolving the solid salt (USP-grade sodium chloride), to produce a bag with a 0.9 w/v % normal saline solution.

An arrangement for providing sterile water for injection purposes is described. A device for heating drinking water above the boiling point, a device for maintaining a chamber inner pressure which lies below the atmospheric pressure, and an electronic controller are provided, and the chamber is equipped with at least one membrane which is impermeable for liquids and a film or plate at a distance from the membrane, wherein steam which is permeated through the membrane is condensed on the film of plate. The membrane and the film or plate form a module, and the condensed water can be removed from the chamber via an outlet as sterile water for injection purposes.

A nanobiocatalytic membrane for a filtration system is provided which includes a filtration membrane and a plurality of nanobiocatalyst nanoparticles associated with the membrane, each of the nanobiocatalyst nanoparticles including a core, a coating at least partially surrounding the core, and a plurality of nanobiocatalysts coupled to the coating. Each of the plurality of nanobiocatalysts includes an antibacterial nanoparticle comprising bismuth, and a quorum quenching agent coupled to the antibacterial nanoparticle. A nanobiocatalyst nanoparticle for use with a water purification system is also provided. A method of forming a nanobiocatalytic membrane for a filtration system and a method of using a nanobiocatalytic membrane in a filtration system are also provided.

The present invention is directed to sunflower protein products, very low in, or free of, beany, green, vegetable or similar flavour notes and useful for the fortification of food and beverage products and prepared without the use of salt in the process. The sunflower protein products of the present invention are obtained by extracting sunflower protein source with water to form an aqueous sunflower solution, at least partially separating the aqueous sunflower protein solution from residual sunflower protein source, adjusting the pH of the aqueous sunflower protein solution to a pH between about 1.5 to about 3.5 to solubilize the bulk of the protein and form an acidified sunflower protein solution then separating the acidified sunflower protein solution from the add insoluble solid material. The acidified sunflower protein solution may be dried following optional concentration and diafiltration to form a sunflower protein product, which may be an isolate. The add insoluble Said material may be washed with acidified water and then dried to form another sunflower protein product. These products may be dried at the acidic pH at which they were prepared or may be adjusted in pH before drying.